CARDIOL THERAPEUTICS INC-A (CRDL) Stock Analyst Earnings Estimates
NASDAQ:CRDL - Nasdaq - CA14161Y2006 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 80K | -100.00% | 2.3M | 45.341M 1,871.35% | 128.03M 182.37% | 194.74M 52.10% | 299.97M 54.04% | 379.84M 26.63% | 450.5M 18.60% | ||||||
| EBITDA YoY % growth | -13.98M -99.43% | -20.46M -46.35% | -38.44M -87.88% | -24.48M -6.97% | -23.46M 28.17% | -32.773M -10.95% | -30.806M 6.00% | -29.36M 4.70% | 28.743M 197.90% | 136.16M 373.72% | 195.38M 43.49% | 300.58M 53.84% | 360.35M 19.88% | 410.63M 13.95% | |
| EBIT YoY % growth | -14.13M -99.01% | -20.69M -46.43% | -38.66M -86.85% | -39.79M -6.93% | -29.07M 27.95% | -40.494M -35.95% | -44.319M -9.45% | -43.248M 2.42% | 2.465M 105.70% | 79.7M 3,133.27% | 142.51M 78.81% | 242.52M 70.18% | 318.37M 31.28% | 384.5M 20.77% | |
| Operating Margin | N/A | N/A | -48,325.00% | N/A | N/A | N/A | N/A | -1,880.35% | 5.44% | 62.25% | 73.18% | 80.85% | 83.82% | 85.35% | |
| EPS YoY % growth | N/A | N/A 12.54% | N/A -10.14% | -0.54 8.50% | -0.44 10.20% | -0.55 -25.18% | -0.51 6.67% | -0.76 -47.82% | 0.23 129.95% | 1.09 380.59% | 1.57 43.27% | 2.41 53.69% | 2.89 20.09% | 3.29 13.82% |
All data in CAD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.13 -11.35% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -10.098M -25.77% |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.18 -100.00% | -0.12 | -0.06 | -47.06% |
| Q2 2024 Q2Q % growth | -0.10 16.67% | -0.13 | 0.03 | 24.59% |
| Q1 2024 Q2Q % growth | -0.14 -27.27% | -0.13 | -0.01 | -5.58% |
| Q4 2023 Q2Q % growth | -0.12 | -0.12 | 0.00 | 1.96% |
| Q3 2023 Q2Q % growth | -0.09 30.77% | -0.12 | 0.03 | 26.47% |
| Q2 2023 Q2Q % growth | -0.12 -20.00% | -0.13 | 0.01 | 5.88% |
| Q1 2023 Q2Q % growth | -0.11 21.43% | -0.15 | 0.04 | 28.10% |
| Q4 2022 Q2Q % growth | -0.12 -9.09% | -0.16 | 0.04 | 24.10% |
| Q3 2022 Q2Q % growth | -0.13 8.96% | -0.15 | 0.02 | 12.10% |
| Q2 2022 Q2Q % growth | -0.10 37.50% | -0.14 | 0.04 | 29.97% |
| Q1 2022 Q2Q % growth | -0.14 46.15% | -0.17 | 0.03 | 19.26% |
| Q4 2021 Q2Q % growth | -0.11 26.67% | -0.15 | 0.04 | 28.10% |
| Q2 2021 Q2Q % growth | -0.16 | -0.14 | -0.02 | -12.04% |
| Q1 2021 Q2Q % growth | -0.26 -136.36% | -0.14 | -0.12 | -82.07% |
| Q4 2020 Q2Q % growth | -0.15 -25.00% | -0.12 | -0.03 | -22.55% |
| Q1 2020 Q2Q % growth | -0.11 | -0.16 | 0.05 | 32.60% |
| Q4 2019 Q2Q % growth | -0.12 | -0.13 | 0.01 | 9.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | 306K | -306K | -100.00% | |
| Q2 2021 Q2Q % growth | 80K | 204K | -124K | -60.78% |
| Q1 2021 Q2Q % growth | 51K | -51K | -100.00% | |
| Q4 2020 Q2Q % growth | 255K | -255K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -19.09% | -8% | -20% |
| Revenue | N/A | N/A | N/A | N/A |